Research piece number 2,000 was published by North Coast Advisors via an Update Report on OPTIMIZERx (OTCBB: OPRX). The following is a brief “Snapshot”
“We had projected break even later in the year, but the combination of approximately 1,500 regular users of SampleMD and the 26 drug offers available in Q1 along with new drug set up fees being charged by OPRX as well as new offers that were added to SampleMD, allowed them to have an encouraging quarter. The Q1 results were highlighted by over 8,000 actual SampleMD print on demand revenue events, or redemptions, in the month of April 2011 alone.”
“The fact that these levels of activity were achieved with only a limited offering of drugs and less than 2,000 users reflects well to us knowing that SampleMD is going to be offering over 45 drug offers (by June 2011) to as many as 30,000 users over the coming six months. (The company is projecting going from 1,500 users in April 2011, to over 20,000-30,000 in the Fall of 2011). And twenty (20) of the new drug offers will be for “top 100 selling” drug brands, which will increase the propensity of the user to be able to actually issue these popular drug offers to their patients.” - Anaylst: Craig T. Stewart, North Coast Advisors.
TSCI Note: Investors can obtain more information on OPTIMIZERx, which is currently being featured in the TSCI Research Spotlight at http://www.thesmallcapinvestor.com/
The OPTIMIZERx report is available free of charge to registered members. Simply click the download button to access the report. Investors who want the report, but are not yet members, just need to click the "Register" link in the upper right hand corner of the site and register for FREE. To go directly to the registration page, please visit: http://www.TheSmallCapInvestor.com/
Stocks with research coverage available include a broad range of companies across multiple industries and include stocks trading on the NYSE, AMEX, NASDAQ and the OTC Markets in the United States. International exchanges include the Canadian exchanges, the TSX, TSX-V and CNQ, as well as the London's AIM & LSE and Germany’s Frankfurt exchange and Australia's ASX.
About The Small Cap Investor
The Small Cap Investor is a financial media company providing the Internet's most efficient platform for the dissemination of equity research, multimedia, news, opinion and commentary as it relates to the small cap markets. The goal of the website is to provide transparency in the small cap market so that investors can conduct proper due diligence. With over 2,000 independent equity reports available, www.TheSmallCapInvestor.com is the web’s leading comprehensive distribution service designed to act as a single, consolidated meeting location for small cap equity research professionals and the investors who seek that research. It is designed for both individual and professional investors and offers free membership, as well as premium services, including access to institutional quality research reports from leading independent equity research firms.
The Small Cap Investor – In The World of Investments, Knowledge is Power ™
The Small Cap Investor
# # #
The Web's premier location for Small Cap Stock Research and Commentary.